Skip to main content
Caplight Logo









Cellivate Technologies

Cellivate Technologies

Private
SingaporeHealthcare & Life Scienceshttps://www.cellivatetech.com/

Last Round

Seed

Aug 6, 2024

Total Funding Raised

$1.19M

Company Overview

Cellivate Technologies is a biotechnology company that develops and manufactures animal-free cell culture solutions and proprietary platform technologies for the pharmaceutical, cultivated meat, and cosmeceutical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

cell culturebiomanufacturingfetal bovine serumFBSmicrocarrierscultivated meatlab-grown meatanimal-free serumextracellular vesiclesEVbioprocessing inputscell adhesionbiotech equipmentsustainable materialsclean manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellivate Technologies Comparables

Compare Cellivate Technologies with similar companies based on industry and business-model similarity.

Cellivate Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Smart MCs
83%
Gelatex Technologies
81%
Multus Biotechnology
80%

Cellivate Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 6, 2024
AcceleratorJun 7, 2023

Key People

Founding team and executive leadership

Viknish Krishnan-Kutty

CEO & Founder

Founding Team

Srinivas Ramasamy

Chief Technology Officer

Executive Team

Cellivate Technologies Investors

Notable investors and investment history

Cellivate Technologies investors
InvestorRounds
NUS Graduate Research Innovation ProgrammeAccelerator
Hatcher+Seed
Venture CatalystsSeed
Venture CatalystsSeed
AntlerSeed
We Founder CircleSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 15, 2025

    Grew 60% QoQ from 5 to 8 employees.

  • Jan 23, 2025

    Monthly visitors increased 192% MoM.

Cellivate Technologies Filings

Explore SEC and related filing metadata, where available.

Cellivate Technologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellivate Technologies's valuation, stock price, and market status.

Is Cellivate Technologies a public or private company?

Cellivate Technologies is a private company.

What is the current stock price of Cellivate Technologies?

Cellivate Technologies is a private company with no public stock price. No recent secondary market data is available.

How much is Cellivate Technologies worth (valuation)?

Valuation information for Cellivate Technologies is not publicly available.

Can I buy Cellivate Technologies stock?

Cellivate Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cellivate Technologies's last funding round?

Cellivate Technologies's most recent funding round was Seed on August 6, 2024.

Who are the main investors in Cellivate Technologies?

Key investors in Cellivate Technologies include Antler AI Disrupt.

Will Cellivate Technologies IPO soon?

No public IPO plans have been announced for Cellivate Technologies.

How can I track Cellivate Technologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellivate Technologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range9
Year Founded2019
Last FundingAug 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?